AGEN - Easy Long from Here
I have been closely following AGEN after their approval of the Shingrix Vaccine. After a couple years of shortage issues, sales this year should be killer (they are partnered with GSK). Look for more positive news to come in about their oncology pipeline as well.
Weekly MACD cross, volume picking up. 1st target 5.00, selling part of my position there and holding the rest until spring.
Weekly MACD cross, volume picking up. 1st target 5.00, selling part of my position there and holding the rest until spring.
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。